CCL23 has been found to be underexpressed in hepatoma cells, and this could lead to CCL23 deletion and reduced CCL23 inhibition via the ESR1/CCL23/CCR1/AKT regulatory axis in liver cancer progression (35). This evidence concerns the gene AKT1 and hepatocellular carcinoma.